The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation
Authors:
- Anne BoulayABAnne Boulay
- Stefano FumagalliSFStefano Fumagalli
- Frederic ZilbermannFZFrederic Zilbermann
- Stephan RuetzSRStephan Ruetz
- Terence O’reillyTOTerence O’reilly
- Francois NattFNFrancois Natt
- Jonathan HallJHJonathan Hall
- Heidi A. LaneHLHeidi A. Lane
- George ThomasGTGeorge Thomas
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Mammalian target of rapamycin (mTOR) inhibitorsCurrent Oncology Reports, 2004
- Antitumor Efficacy of Intermittent Treatment Schedules with the Rapamycin Derivative RAD001 Correlates with Prolonged Inactivation of Ribosomal Protein S6 Kinase 1 in Peripheral Blood Mononuclear CellsCancer Research, 2004
- The role of p53 in chemosensitivity and radiosensitivityOncogene, 2003
- Proteasome-Mediated Degradation of p21 via N-Terminal UbiquitinylationCell, 2003
- Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivinBlood, 2003
- Mammalian TOR: A Homeostatic ATP SensorScience, 2001
- Pathways governing G1/S transition and their response to DNA damageFEBS Letters, 2001
- The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblastsThe EMBO Journal, 1999
- Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustardOncogene, 1997
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993